1 / 7

NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update

NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update. NVAC Meeting February 3, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg Professor of Maternal and Child Health Department of Society, Human Development, and Health Harvard School of Public Health. Charge.

rufin
Download Presentation

NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update NVAC Meeting February 3, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg Professor of Maternal and Child Health Department of Society, Human Development, and Health Harvard School of Public Health

  2. Charge To conduct independent, rapid reviews of available federal immunization safety monitoring data for the 2009 H1N1 influenza vaccines

  3. Stephen Cantrill Vicky Debold Kathryn Edwards Chris Carlson Theodore Eickhoff Susan Ellenberg Marie McCormick1,2 Laura Riley1 Mark Sawyer Working Group Members 1NVAC Member 2NVAC VSRAWG Chair

  4. Progress • Meets bi-weekly to review H1N1 safety data • Initial meeting Nov. 2, 2009 • 6 meetings to-date • Reports for NVAC monthly • 2 reports reviewed to date • December 16, 2009 • January 20, 2010 • Transmitted to the ASH ASPR, CDC, FDA, NIH, HIS, CMS, DoD and VA • Available on NVPO website at: http://www.hhs.gov/nvpo/nvac/reports/index.html

  5. Report Conclusions “Working Group concluded that the data are adequate to assess the presence or absence of a signal. Additionally, the Working Group concluded that the data do not favor a signal between the outcomes examined and the H1N1 vaccines. A signal is defined as an event that could be temporally occurring more often after vaccine receipt than anticipated by chance alone.”

  6. Moving Forward • Working Group will continue to review the safety data of H1N1 vaccines • Reports from the VSRAWG will be presented on NVAC conference calls on the following dates: • February 26 • March 23 • April 21 • May 19

More Related